Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.
- Central Vermont Medical Center/National Life Cancer Treatment — Berlin Corners, Vermont
- University of Vermont Medical Center — Burlington, Vermont
- University of Vermont and State Agricultural College — Burlington, Vermont
- Dartmouth Cancer Center - North — Saint Johnsbury, Vermont